The interventional radiology section is actively involved in clinical research and have participated in many pivotal trials. Some of our active trials include:
- ATTRACT. A multicenter pivotal trial evaluating pharmacomechanical thrombolysis for DVT in comparison to standard of care anti-coagulation. National PI is Suresh Vedantham, M.D., a member of the MIR interventional faculty.
- E1208. A Trail comparing TACE+/-Sorafenib for non-transplants patients who have unresectable HCC.
- EPOCH. A phase 3 clinical trial evaluating TheraSpheres in patients with metastatic colorectal carcinoma of the liver who have failed first-line chemotherapy.
- A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma.